Skip to content
FDA Move on Abortion Pill Prompts GOP Senators to Raise Safety Concerns
Charles Hilu /

FDA Move on Abortion Pill Prompts GOP Senators to Raise Safety Concerns

The approval of a generic mifepristone renews skepticism about the Trump administration’s opposition to abortion.
Medication to terminate a pregnancy can be seen in a gynecologist’s office in front of an ultrasound image. (Photo by Hendrik Schmidt/picture alliance/Getty Images)
Medication to terminate a pregnancy can be seen in a gynecologist's office in front of an ultrasound image. (Photo by Hendrik Schmidt/picture alliance/Getty Images)

Pro-life advocates reacted with shock at the beginning of the month when the Food and Drug Administration approved a generic version of the abortion pill. They responded by urging President Donald Trump’s administration to reverse the greenlighting of what is now the third mifepristone product on the market in the United States.

Want to see more of The Dispatch in Google search?

Add Us as a Preferred Source

Charles Hilu is a reporter for The Dispatch based in Washington, D.C. Before joining the company in 2024, he was the Collegiate Network Fellow at the Washington Free Beacon and interned at both National Review and the Washington Examiner. When he is not chasing down lawmakers on Capitol Hill, he is probably listening to show tunes or following the premier sports teams of the University of Michigan and city of Detroit.

More We Think You’d Like

Loading